FIELD: medicine.
SUBSTANCE: etiotropic therapy is preceded by 2-3 sessions of cascade plasma filtration in an amount of 1-1.2 amounts of circulating plasma. The prepared plasma is passed through capillary filters with a certain pore diameter. In viral hepatitis, the pore diameter makes 30 nm, and in autoimmune hepatitis - 10 nm.
EFFECT: method provides conducting the effective therapy of the given pathology by selecting filters with the optimum pore diameter for various types of chronic hepatitis.
4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
| METHOD FOR PREDICTING THE FLOW AND RESULTS OF ACUTE VIRAL HEPATITIS B AND C IN TEENAGERS | 2004 |
|
RU2268470C2 |
| METHOD FOR PROVIDING HIGHER EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2011 |
|
RU2468815C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2012 |
|
RU2486526C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATMENT OF HEPATITIS C WITH THE CHILDREN OF THE FIRST YEAR OF LIFE | 2016 |
|
RU2646510C1 |
| METHOD FOR SELECTION OF MEDICINAL PREPARATIONS FOR TREATMENT OF PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2002 |
|
RU2221243C1 |
| METHOD OF HEPATITIS TYPE C TREATMENT | 2006 |
|
RU2336096C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CNS ORGANIC LESIONS IN CHILDREN DURING THE ACUTE PERIOD | 2017 |
|
RU2648215C1 |
| METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
| METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
